Des-gamma-carboxy prothrombin (DCP) as a prognostic biomarker in patients with advanced hepatocellular carcinoma treated with atezolizumab/bevacizumab.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Elizabeth Conner, Jeremy Chang, Adam Burgoyne
Institutions: University of California San Diego, Moores Cancer Center
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4400415382